Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience). [electronic resource]
Producer: 20180309Description: 597-604 p. digitalISSN:- 1432-0584
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Child
- Child, Preschool
- Female
- Follow-Up Studies
- Humans
- Imatinib Mesylate -- adverse effects
- Leukemia, Myeloid, Accelerated Phase -- diagnosis
- Leukemia, Myeloid, Chronic-Phase -- diagnosis
- Male
- Middle Aged
- Practice Patterns, Physicians'
- Prognosis
- Protein Kinase Inhibitors -- adverse effects
- Retrospective Studies
- Splenomegaly -- etiology
- Survival Analysis
- Tumor Burden -- drug effects
- Tunisia -- epidemiology
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.